Picture of Taro Pharmaceutical Industries logo

TARO — Taro Pharmaceutical Industries News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedMid Cap

Taro Pharmaceutical Industries Ltd expected to post earnings of 19  cents a share - Earnings Preview

* Taro Pharmaceutical Industries Ltd  TARO.N   TARO.K  is
expected
to show a rise in quarterly revenue when it reports  results on
May 23. 
    * The Haifa Israel-based   company is expected to report  a
0.2% increase in revenue to $139.202 million from $138.98
million a year ago, according to the estimate from one analyst,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Taro Pharmaceutical
Industries Ltd is for earnings of 19 cents per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Taro
Pharmaceutical Industries Ltd is $35​, above​ its last closing
price of $28.98. ​​​

This summary was machine generated May 19 at 20:16 GMT.  All
figures in US dollars  unless otherwise stated

Recent news on Taro Pharmaceutical Industries

See all news